GT Medical Technologies

company

About

GT Medical Technologies has developed a unique therapeutic approach to the treatment of brain tumors.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$3M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2 Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3M
GT Medical Technologies has raised a total of $3M in funding over 2 rounds. Their latest funding was raised on Jan 31, 2018 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 31, 2018 Seed $3M 1 Medical Technology Venture Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
1
GT Medical Technologies is funded by 1 investors. Medical Technology Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Medical Technology Venture Partners Yes Seed